Dr Byrd discusses optimizing Ibrutinib & Idela... - CLL Support

CLL Support

23,800 members40,602 posts

Dr Byrd discusses optimizing Ibrutinib & Idelalisib.

5 Replies

You need to be a member of this community to see this post.

Read more about...

Featured Content

Jump to replies
Learn from others' experiences, meet people who understand & feel empowered to take control of your health.
Featured by HealthUnlocked
Seeking support and information for Chronic Lymphocytic Leukaemia?
Featured by CLL Support
Learn from others' experiences, meet people who understand & feel empowered to take control of your health.
5 Replies

You need to be a member of this community to see hidden responses.

Not what you're looking for?

You may also like...

Dr. Mato on what really happens when we must stop our ibrutinib or idelalisib

Friends, I hope my US-based readers had a happy healthy holiday weekend. This past weekend, in...
bkoffman profile image
CLL CURE Hero

Dr Sharman's thoughts on the race for FDA Approval for Obinituzumab, Ibrutinib and Idelalisib

Following Gilead's announcement regarding Idelalisib:...
AussieNeil profile image
Partner

Dr. Byrd on COVID-19

Hi, Dr. John Byrd is not only a valued member of our medical advisory board and a world leader in...
bkoffman profile image
CLL CURE Hero

Dr Peter Hillmen of Leeds, UK discusses the place for Idelalisib in CLL treatment (Patient Power Video)

In this short video taken at iwCLL Collogne Germany, Andrew Schorr interviews Dr Hillmen: "As a...
AussieNeil profile image
Partner

Your opportunity to support affordable access to Ibrutinib and Idelalisib for Aussies - Submissions close next Wed 7th October

Australia's November Pharmaceutical Benefits Advisory Committe (PBAC) meeting will consider listing...
AussieNeil profile image
Partner